ANI Pharmaceuticals
ANIP
55,57 €
Share price
-3.46%
Change (1 day)
-5.39%
Change (1 year)
Categories
Earnings for ANI Pharmaceuticals (ANIP)
Earnings in 2025 (TTM): -€25.17 Million
According to ANI Pharmaceuticals's latest financial reports the company's current earnings are €0.67 Billion. In 2024 the company made an earning of -€19.23 Million a decrease over its 2023 earnings that were of €17.2 Million. The earnings displayed on this page is the company's Pretax Income.
Earnings history for ANI Pharmaceuticals from 2000 to 2025
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2025 (TTM)  | -€25.17 Million | 30.88% |
| 2024 | -€19.23 Million | -211.78% |
| 2023 | €17.2 M | -131.71% |
| 2022 | -€54.25 Million | 11.79% |
| 2021 | -€48.53 Million | 115.92% |
| 2020 | -€22.48 Million | -922.36% |
| 2019 | €2.73 M | -84.26% |
| 2018 | €17.35 M | 22.64% |
| 2017 | €14.15 M | 88.4% |
| 2016 | €7.51 M | -60.07% |
| 2015 | €18.81 M | 12.15% |
| 2014 | €16.77 M | -899.29% |
| 2013 | -€2.1 Million | -91.27% |
| 2012 | -€24.04 Million | -46.02% |
| 2011 | -€44.53 Million | 17.96% |
| 2010 | -€37.75 Million | 18% |
| 2009 | -€31.99 Million | 103.96% |
| 2008 | -€15.69 Million | 128.68% |
| 2007 | -€6.86 Million | -330.34% |
| 2006 | €2.97 M | -136.98% |
| 2005 | -€8.06 Million | -24.17% |
| 2004 | -€10.62 Million | 102.51% |
| 2003 | -€5.25 Million | 58.68% |
| 2002 | -€3.31 Million | 39.58% |
| 2001 | -€2.37 Million | -24.1% |
| 2000 | -€3.12 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Jazz Pharmaceuticals JAZZ | €0.31 B | -1,414.01% | 🇮🇪 Ireland |
 Evoke Pharma
EVOK | -€3.97 Million | -83.39% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | €0.39 B | -1,747.31% | 🇮🇱 Israel |
 Pfizer PFE | €8.95 B | -37,621.77% | 🇺🇸 USA |
 Lannett Company LCI | -€0.18 Billion | 619.55% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | -€0.19 Billion | 688.13% | 🇺🇸 USA |
 Cardinal Health CAH | €1.94 B | -8,264.01% | 🇺🇸 USA |
 Novartis NVS | €12.91 B | -54,229.17% | 🇨🇭 Switzerland |
 Royalty Pharma RPRX | €1.74 B | -7,411.54% | 🇬🇧 UK |